MedTrace Logo

Light at Night Study

NCT04251234 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2021-08-12

No results posted yet for this study

Summary

The purpose of this mechanistic study is to examine light sensitivity (melatonin suppression) in people with bipolar depression I, and compare it to healthy controls. This is not a treatment study.

Conditions

Interventions

OTHER

Light intensity, ~30 lux

\~30 lux compared to very dim light baseline condition \<1 lux

OTHER

Baseline light intensity, <1 lux

Very dim light condition

Sponsors & Collaborators

Principal Investigators

  • Helen Burgess, PhD · University of Michigan

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2021-08-04
Completion
2021-08-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04251234 on ClinicalTrials.gov